Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors.

Des Jarlais DC, Arasteh K, McKnight C, Hagan H, Perlman DC, Torian LV, Beatice S, Semaan S, Friedman SR.

Drug Alcohol Depend. 2010 Jun 1;109(1-3):154-60. doi: 10.1016/j.drugalcdep.2009.12.028. Epub 2010 Feb 16.

2.

"Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001.

Des Jarlais DC, Perlis T, Arasteh K, Hagan H, Milliken J, Braine N, Yancovitz S, Mildvan D, Perlman DC, Maslow C, Friedman SR.

J Acquir Immune Defic Syndr. 2004 Feb 1;35(2):158-66.

PMID:
14722449
3.

HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.

Broz D, Wejnert C, Pham HT, DiNenno E, Heffelfinger JD, Cribbin M, Krishna N, Teshale EH, Paz-Bailey G; National HIV Behavioral Surveillance System Study Group.

MMWR Surveill Summ. 2014 Jul 4;63(6):1-51.

4.

A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.

Sarkar S, Panda S, Sarkar K, Hangzo CZ, Bijaya L, Singh NY, Das N, Agarwal A, Chatterjee A, Deb BC, et al.

Indian J Public Health. 1995 Jul-Sep;39(3):86-92.

PMID:
8690497
5.

Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.

Neaigus A, Zhao M, Gyarmathy VA, Cisek L, Friedman SR, Baxter RC.

J Urban Health. 2008 May;85(3):309-22. doi: 10.1007/s11524-008-9271-1. Epub 2008 Mar 14.

6.

Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992.

Des Jarlais DC, Friedman SR, Sotheran JL, Wenston J, Marmor M, Yancovitz SR, Frank B, Beatrice S, Mildvan D.

JAMA. 1994 Jan 12;271(2):121-7.

PMID:
8264066
7.

Condom use with primary partners among injecting drug users in Bangkok, Thailand and New York City, United States.

Vanichseni S, Des Jarlais DC, Choopanya K, Friedmann P, Wenston J, Sonchai W, Sotheran JL, Raktham S, Carballo M, Friedman SR.

AIDS. 1993 Jun;7(6):887-91.

PMID:
8363764
8.

Combined HIV prevention, the New York City condom distribution program, and the evolution of safer sex behavior among persons who inject drugs in New York City.

Des Jarlais DC, Arasteh K, McKnight C, Feelemyer J, Hagan H, Cooper HL, Perlman DC.

AIDS Behav. 2014 Mar;18(3):443-51. doi: 10.1007/s10461-013-0664-0.

9.

High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs.

Uusküla A, Kals M, Rajaleid K, Abel K, Talu A, Rüütel K, Platt L, Rhodes T, Dehovitz J, Des Jarlais D.

J Public Health (Oxf). 2008 Jun;30(2):119-25. doi: 10.1093/pubmed/fdn014. Epub 2008 Feb 28.

10.

Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City.

Des Jarlais DC, Arasteh K, McKnight C, Hagan H, Perlman D, Friedman SR.

Drug Alcohol Depend. 2009 Apr 1;101(1-2):88-91. doi: 10.1016/j.drugalcdep.2008.11.007. Epub 2008 Dec 23.

PMID:
19108958
11.

Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001.

Des Jarlais DC, Perlis T, Arasteh K, Torian LV, Hagan H, Beatrice S, Smith L, Wethers J, Milliken J, Mildvan D, Yancovitz S, Friedman SR.

AIDS. 2005 Oct;19 Suppl 3:S20-5.

PMID:
16251819
12.

HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years.

Des Jarlais DC, Arasteh K, Friedman SR.

Subst Use Misuse. 2011;46(2-3):131-9. doi: 10.3109/10826084.2011.521456.

PMID:
21303233
13.

[Risk behaviors for HIV transmission among the recent clients of a syringe-exchange program in Madrid, 1993].

Bravo Portela MJ, Barrio Anta G, de la Fuente de Hoz L, Colomo Gómez C, Royuela Morales L, Estébanez Estébanez P.

Gac Sanit. 1996 Nov-Dec;10(57):261-73. Spanish.

PMID:
9072510
14.

Unstable housing as a factor for increased injection risk behavior at US syringe exchange programs.

Des Jarlais DC, Braine N, Friedmann P.

AIDS Behav. 2007 Nov;11(6 Suppl):78-84. Epub 2007 Apr 20.

PMID:
17447132
15.

Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies.

Rudolph AE, Crawford ND, Ompad DC, Benjamin EO, Stern RJ, Fuller CM.

J Am Pharm Assoc (2003). 2010 Mar-Apr 1;50(2):140-7. doi: 10.1331/JAPhA.2010.09193.

16.

Dual HIV risk: receptive syringe sharing and unprotected sex among HIV-negative injection drug users in New York City.

Neaigus A, Reilly KH, Jenness SM, Hagan H, Wendel T, Gelpi-Acosta C.

AIDS Behav. 2013 Sep;17(7):2501-9. doi: 10.1007/s10461-013-0496-y.

PMID:
23640654
17.

"Why I am not infected with HIV": implications for long-term HIV risk reduction and HIV vaccine trials.

Des Jarlais DC, Vanichseni S, Marmor M, Buavirat A, Titus S, Raktham S, Friedmann P, Kitayaporn D, Wolfe H, Friedman SR, Mastro TD.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Dec 15;16(5):393-9.

PMID:
9420319
18.

HIV incidence among injecting drug users in New York City syringe-exchange programmes.

Des Jarlais DC, Marmor M, Paone D, Titus S, Shi Q, Perlis T, Jose B, Friedman SR.

Lancet. 1996 Oct 12;348(9033):987-91.

PMID:
8855855
19.

Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs.

Des Jarlais DC, Arasteh K, Hagan H, McKnight C, Perlman DC, Friedman SR.

Am J Public Health. 2009 Oct;99 Suppl 2:S445-51. doi: 10.2105/AJPH.2008.159327.

20.

Injection drug use and risk of HIV transmission among homeless men with mental illness.

Susser E, Miller M, Valencia E, Colson P, Roche B, Conover S.

Am J Psychiatry. 1996 Jun;153(6):794-8.

PMID:
8633692

Supplemental Content

Support Center